Bristol Myers Squibb

Oxford BioTherapeutics signs T-cell engager collaboration with Bristol Myers Squibb for solid tumour targets Manufacturing Chemist11:33GSK Roche Pharma

Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb PharmaTimes14:10Pharma T-Cells

Why Bristol Myers Squibb (BMY) outpaced the stock market today Zacks23:49S&P 500 Stock Markets (World) Stock Market (US)

Bristol Myers Squibb (BMY) rises higher than market: Key facts Zacks23:49S&P 500 Stock Markets (World) Stock Market (US)

Bristol Myers Squibb (BMY) ascends but remains behind market: Some facts to note Zacks23:55S&P 500 Stock Markets (World) Stock Market (US)

Bristol Myers Squibb company (BMY) is a trending stock: Facts to know before betting on it Zacks15:01

Investors heavily search Bristol Myers Squibb company (BMY): Here is what you need to know Zacks15:08

Bristol Myers Squibb evolves and expands multiple myeloma programme PMLiVE12:59Blood Cancer Cancer

Bristol-Myers Squibb earnings preview: What to expect Barchart13:54Pharma

Why Bristol Myers Squibb (BMY) is a top value stock for the long-term Zacks15:48

Latest News

In the last 6 hours

Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a… Business Wire (Press Release)12:08

In the last 7 days

A Look At Bristol Myers Squibb (BMY) Valuation As Undervaluation Debate Resurfaces Simply Wall St14:47 17-Apr-26

Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today Zacks23:49 16-Apr-26

Beeline raises $300m for BMS drugs, and other biofinancings pharmaphorum12:27 16-Apr-26

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks15:01 15-Apr-26

STAT Plus: New Bain biotech startup, building on BMS drugs, gets a name and a CEO STAT12:04 15-Apr-26

In the last month

Bristol Myers Squibb evolves and expands multiple myeloma programme PMLiVE12:59 13-Apr-26

Which Dividend Pharma Stock Should a Value Investor Choose Today? The Motley Fool02:00 13-Apr-26

BMS and Oxford BioTherapeutics join forces in TCE discovery pact Pharmaceutical Technology17:32 10-Apr-26

2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap The Motley Fool11:37 10-Apr-26

Oxford BioTherapeutics signs T-cell engager collaboration with Bristol Myers Squibb for solid tumour targets Manufacturing Chemist11:33 10-Apr-26

Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb PharmaTimes14:10 9-Apr-26

Bristol-Myers Squibb Earnings Preview: What to Expect Barchart13:54 9-Apr-26

Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts Zacks23:49 8-Apr-26

A Look At Bristol Myers Squibb (BMY) Valuation After US Tariff Threats Hit Pharma Stocks Simply Wall St02:42 6-Apr-26

Is Positive Camzyos Adolescent Trial Data Altering The Investment Case For Bristol-Myers Squibb (BMY)? Simply Wall St06:35 4-Apr-26

Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term Zacks15:48 3-Apr-26

AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know Barchart20:42 2-Apr-26

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know Zacks15:08 2-Apr-26

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report? Zacks18:14 1-Apr-26

Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb… Business Wire (Press Release)13:03 1-Apr-26

Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note Zacks23:55 31-Mar-26

Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in … Business Wire (Press Release)12:01 31-Mar-26

Bristol Myers Squibb adding 3 medications on TrumpRx Fox News21:56 30-Mar-26

Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral… Business Wire (Press Release)11:03 28-Mar-26

[Interview] Cancer care is one trip -- getting there is another: BMS expands support in Korea Korea Biomedical Review08:51 27-Mar-26

BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma PMLiVE11:02 26-Mar-26

Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing Zacks22:52 25-Mar-26

Why Bristol-Myers Squibb (BMY) Stock Is Up Today Barchart20:12 25-Mar-26

New Recursion CMO Puts Oncology Experience At Center Of Investor Focus Simply Wall St17:35 25-Mar-26

Will the Recent Label Expansion of BMY's Opdivo Boost Its IO Franchise? Zacks17:06 25-Mar-26

Bristol Myers Squibb Leans On AI ALS Pact As Valuation Question Persists Simply Wall St05:32 25-Mar-26

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill. The Motley Fool11:19 24-Mar-26

Is Bristol Myers Squibb (BMY) Attractively Priced After Recent Share Price Weakness Simply Wall St02:12 24-Mar-26

Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend? The Motley Fool20:55 23-Mar-26

FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma Zacks16:33 23-Mar-26

Jefferies resumes Oxford BioMedica coverage with 'buy' rating and 34% upside target Proactive Investors (UK)14:19 23-Mar-26

Three New Studies Show Viz.ai’s Cardio Suite Speeds Detection of Cardiac Disease and Improves… Business Wire (Press Release)13:05 23-Mar-26

BMS wins dual immunotherapy-first approvals in classical Hodgkin Lymphoma European Pharmaceutical Review12:15 23-Mar-26

insitro and Bristol Myers Squibb Collaboration Expanded with Nomination of New Targets Business Wire (Press Release)12:06 23-Mar-26

Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at… Business Wire (Press Release)11:02 23-Mar-26

BMS secures FDA and EC approvals for Opdivo in Hodgkin Lymphoma Pharmaceutical Business Review09:55 23-Mar-26

view more headlines

21 Apr 12:08

Bristol Myers Squibb News

NewsNow brings you the latest news from the world’s most trusted sources on Bristol Myers Squibb. NewsNow aims to be the world’s most accurate and comprehensive Bristol Myers Squibb news aggregator, bringing you the latest headlines automatically and continuously 24/7.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.